Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-26-006317
Filing Date
2026-02-20
Accepted
2026-02-20 16:09:54
Documents
1
Period of Report
2026-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3272
  Complete submission text file 0001140361-26-006317.txt   4814
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TELIGENT, INC. 105 LINCOLN AVENUE BUENA NJ 08310
Business Address
Wilson Martin (Reporting) CIK: 0001704342 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 26659955